Background: Videolaryngoscopy (VL) is increasingly used, but not yet routine practice, for tracheal intubation. Few departments formally trial equipment before adopting it into practice. We describe the decision-making and implementation processes that our department used when introducing universal VL, with the C-MAC © (Karl Storz, Germany),
Several authors have called for videolaryngoscopy (VL) to be used either as first choice or for all intubations, 1e5 but its use is currently much lower, being 3% in one large series where VL was used as a rescue technique. 6 One editorial stated that 'videolaryngoscopes should replace direct laryngoscopes as smart phones have replaced standard cell phones: they should be used for all intubations'. 1 A recent survey examining UK use of VL showed that, although 92% of hospitals have VL available in theatre and 50% in the intensive care unit (ICU), their use is relatively uncommon; 50% of those who have VL available for anaesthesia reported infrequent routine use and none reported universal use. 7 Choice of videolaryngoscope in the same survey was through formal evaluation in only 18% of hospitals. 7 In a 2011 North American survey of residency training, VL was taught in 80% of programmes. 8 Our department has 16 operating theatres spread over three separate locations, and uses~5000 laryngoscope blades for in-theatre intubation each year (intubation rate~33% of general anaesthetics). After manufacturing changes to our usual standard Macintosh laryngoscope design, the department planned to replace all current Macintosh laryngoscope stock, presenting an opportunity to reconsider our future needs. We were also aware that we were not fully compliant with the Medicines and Healthcare products Regulation Authority (MHRA) guidance on decontamination of laryngoscope blades and handles, which states that decontamination of both the laryngoscope blade and handle is necessary.
Based on previous evaluations of this and other devices and review of the literature, the anaesthetic department judged that the device was the best candidate for our departmental conversion to universal VL. The C-MAC was chosen because of its similarity to the conventional Macintosh laryngoscope, the availability of an extra-curved blade for difficult procedures, the inclusion of a screen separate from the laryngoscope blade, and the considerable experience already gathered with the device by ourselves, supported by the anaesthetic literature. Thus, our conversion to universal VL entailed an expansion of current provision rather than introduction of a new device.
Methods
After departmental discussion, we undertook a six-stage, structured process to explore the adoption of VL with the C-MAC © as our default first-choice intubation technique (which we termed 'universal videolaryngoscopy'), with removal of Macintosh laryngoscopy from routine practice. The six steps were as follows. 
Ethics and statistical analyses
The decision to convert to the C-MAC © videolaryngoscope for a trial period was an operational decision taken by the department of anaesthesia. No data were collected from patients. There was therefore no indication for the project to be reviewed by an Ethics Committee. Storz had no other involvement in the conduct of the trial, or in evaluation of results, or in decision-making consequent on the trial. This report is purely observational, and no statistical analysis other than reporting of simple proportions of replies to surveys has been included.
Surveys were conducted as follows: (i) before the trial (anaesthetists); (ii) at the mid-point of the trial (anaesthetists and anaesthetic assistants); (iii) at the end of the trial (anaesthetists); (iv) 6 months after the trial (anaesthetists); and (v) 8 months after the trial (anaesthetic trainees who were in the department during the 2 month feasibility trial), to determine the impact (or lack of impact) of universal VL on their airway training, and on their development as an anaesthetist.
Results

Pre-trial survey
The results of the pre-trial survey are summarized in Tables 1  and 2 . Forty-seven of 56 (84%) departmental members replied to the survey: 21 consultants, six non-consultant career grade (NCCG) doctors, and 26 trainees of all levels of experience.
Thirty-two per cent of respondents unreservedly supported a change to VL and 28% were against it ( Table 2 ). Trainees were notably more likely to be against conversion. Reservations, disinclination to change, or both were reported by 57% of consultants, 66% of NCCGs, 57% of specialist trainees, and 92% of junior trainees. Forty specific concerns were reported; of these, 65% related to training, with 84% of junior trainees' expressing concern than universal VL use would negatively affect their training. Other concerns related to patient safety (17% of all concerns, 65% of consultants' concerns) and team dynamics (5% of all concerns).
Feasibility trial
The feasibility trial took place without incident. The spare unit was not called into use.
Mid-trial survey
Thirty-seven (67%) anaesthetists (16 consultants, six NCCGs, and 15 trainees) and 19 (50%) anaesthetic assistants responded to the mid-trial survey.
This survey examined the following: (i) delays in service delivery attributable to unavailability of the C-MAC © at induction of anaesthesia, during maintenance, or at extubation; (ii) reliability (device failure); and (iii) failed intubations. During the trial,~830 intubations and extubations took place. There were seven reports of a brief delay in induction or extubation owing to a C-MAC © not being immediately available (7/1660 interventions, 0.4%), two (2/830, 0.2%) reports of failure of the device (power failure) during preparation for induction, and one (1/830, 0.1%) report of a failed intubation with the device. Fifty-seven per cent of anaesthetists reported that the use of a C-MAC © for all patients had had a positive impact on their practice and 8% a negative impact (Table 3) . Seventy-nine per cent of anaesthetic assistants judged that the trial had had a positive impact on their practice and 5% a negative impact (Table 3) . After the mid-trial survey, the need to plug the units into a power source (to prevent loss of battery power) was reinforced. To ensure availability, 'C-MAC stations' were created in each theatre suite, which included a whiteboard for recording the location to which the device had been taken (Fig. 1 ).
End-of-trial survey
Forty-four (79%) anaesthetists replied (20 consultants, six NCCGDs, and 18 trainees).
There were no new reports of clinical delays, device failures, or failed intubations. Eighty-two per cent of anaesthetists reported that the use of a C-MAC © for all patients had had a positive impact on their practice and 2% reported a negative effect (Table 3) . Forty-three per cent of anaesthetists unreservedly supported a change to VL and 11% were against it ( Table 2) .
Six-month post-trial survey
Twenty-seven (90%) consultant and NCCG anaesthetists responded to the final survey. Trainees were not included in this survey because these trainees had not been involved in the previous feasibility trial. Eighty-nine per cent of respondents unreservedly supported a change to VL and 4% were against it ( Table 2 ).
The change in support for conversion to the C-MAC © over time is shown in Fig. 2 . 
Survey of previous trainees
A survey was sent to the 20 trainees who had been in the department during the feasibility trial and who had subsequently moved to different hospitals; 19 replied. Regarding benefits of VL in training: 14/19 (74%) trainees reported that trainers were able to assist or coach them by looking at the screen; 11/19 (52%) reported that trainers were more likely to give them the time needed to complete an intubation themselves without the trainer taking over; and 8/19 (42%) reported that trainers were more likely to allow them to attempt a potentially difficult intubation than they would otherwise have been without the C-MAC © . Regarding overall impact on training: 16 (84%) reported a positive impact; three (16%) reported a neutral impact; and none reported a negative impact.
Eighteen of 19 (95%) reported that they would support a changeover to universal VL.
Business case and implementation
After the 6 month post-trial survey and subsequent departmental discussion, a unanimous departmental decision was made to convert to universal VL use for all adult intubations in theatre and ICU, using C-MAC © VL as the default intubation technique. Throughout the next 3yr, the C-MAC © (and standard equipment) remained available in all theatres, and during that time the C-MAC © was used for~95% of all intubations. In March 2017, a business case was accepted, leading to the adoption of universal VL throughout theatres and ICU.
Discussion
We believe that this is the first report of conversion to VL as a routine first-choice option throughout a hospital's anaesthetic and ICU practice. We are aware of one hospital in Italy that reported conversion to the Glidescope in theatre several years ago, 11 and it is possible that others have done this without reporting it. It is unlikely that this has occurred in the UK, because a recent survey reported that no hospital in the UK was using VL routinely in the main operating theatre suite. 7 We made two major decisions: (i) that there was merit in changing to universal VL; and (ii) to choose the C-MAC © as our videolaryngoscope.
There is increasing interest in and numerous publications describing benefits of VL, but its role in clinical practice remains hotly debated. 1,12e18 We believe this is, in part, because of the wide variety of different videolaryngoscopes available and a lack of evidence to discriminate between their performance. For example, a Macintosh-shaped blade videolaryngoscope is unlikely to improve the view of the larynx as much as a more angulated device, but has the advantage that it can be used for both direct laryngoscopy and VL. An angulated videolaryngoscope introduces technical difficulties to 19 Notably, several recent UK airway deaths have been associated with failure to see the larynx during attempts at intubation. Recent evidence also indicates that >90% of such difficult intubations are not predicted. 25 Overall, this provided us with enough evidence to decide that changing to universal VL was in our patients' best interests. We chose the C-MAC © system as our videolaryngoscope for several reasons, but we accept that others might reach different conclusions from the same evidence. First, the C-MAC © provides two systems: a standard Macintosh blade and a more curved D-lade. The standard blade has been shown to improve the view of the larynx during routine use 26 and in those with predicted difficult, 27 actual difficult, 28 or failed intubation. 22 It has been shown to reduce the use of airway adjuncts. 27 Importantly, however, it can also be used for direct laryngoscopy, and indeed, use of the C-MAC © system has been
shown to improve teaching of direct laryngoscopy in more than one paper. 29, 30 We believe this 'direct and videolaryngoscopy' is an optimal choice for first attempts at intubation in terms of ease, success, speed, and skill retention.
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The D-blade is supported by published evidence in terms of the management of difficult laryngoscopy. 31 have an important role in teaching, and we judged that the C-MAC © provided the opportunity to benefit patients and trainees alike, without compromising either. We therefore decided that we needed a videolaryngoscope with both a Macintosh and a 'difficult blade'. At that time, the C-MAC © was the only system providing both options, although since then the Glidescope system has also introduced a Macintoshshaped blade to support its original angulated blade. Although other systems do offer both 'routine' and 'difficult' blades, the similarity of the former to the Macintosh is variable and the evidence of benefit of the latter generally lacking. Third, we chose a reusable rather than single-use option based on environmental, performance, and lastly, cost considerations. One of the barriers to implementation of universal VL was decontamination of blades, and at the time of conversion the C-MAC © was the only videolaryngoscope with both
Macintosh and angulated shaped blades that could be decontaminated in the sterile services department, meeting the requirements set by our infection control team. Fourth, we preferred a videolaryngoscope system with a screen discrete from the VL blade, because of the benefits this brings in terms of team work, communication, and human factors. 13, 34 Fifth, our department was familiar with the C-MAC © , having had it available for use since 2010 for emergency use. The C-MAC © had been chosen by our department over other devices at that time after careful consideration of the issues discussed above.
We chose not to collect detailed data on intubation success rates, complications, or adverse events because we judged that the available literature provided better evidence than we would obtain in a local survey of practice. We were not intending to perform a comparison of techniques, but rather to implement change based on existing evidence and thus improve the quality of care provided. We did collect data on failed intubation rates during the survey and noted a rate of <0.1% after introduction of universal VL.
It is notable that, before our trial of universal VL, fewer than one-third of the department were fully in favour of conversion. The commonest concern raised was the impact on training, and the most vociferous opponents were trainees. Both trainers and trainees were cognisant that, even with universal VL in our hospital, trainees would subsequently move to other hospitals where VL might not be so widely available. During and after the trial, these concerns disappeared and it became apparent that the C-MAC © was an asset to training. Ninety-two per cent of trainees, surveyed before the feasibility trial, reported concerns about the impact of VL on training, but 6 months after the trial 89% of the same trainees reported benefit to their training and none reported disadvantage. Not only can VL be used by a supervisor to observe the precise actions of a trainee during direct laryngoscopy, but the trainer can also identify anatomical structures, advise, and coach in real time. 34 The intubation can be recorded and used for reflective teaching. 35 Importantly, we found that, because the trainer can observe the intubation, trainers were willing to: (i) allow trainees to attempt intubations that they would not otherwise have been willing to (safe in the knowledge that every action would be seen and any difficulty would be immediately apparent); (ii) allow the trainee to persist, for longer than they would without vision, when an intubation was not immediately easy; and (iii) coach the intubator during such procedures, increasing the likelihood of success, benefiting both patient and trainee.
One of the more surprising impacts of the project was the considerable enthusiasm for VL shown by our anaesthetic assistants. In the early phase of the project, anaesthetic assistants were required to decontaminate the blades by hand, significantly increasing their workload, and at interim stages in the project a lack of C-MAC © blades also increased their workload. Despite this, the anaesthetic assistants were strong and vocal advocates of the introduction of VL, noting their increased involvement in airway management; in particular, they reported an increased ability to see problems early and anticipate the next step, an increased ability to have additional equipment immediately to hand if needed by the intubator, and increased ability to see the accuracy and effectiveness of cricoid force or other laryngeal manipulations and make adjustments as necessary. 36, 37 It was best described by one who stated that 'videolaryngoscopy changes intubation from me to we'. There were, however, many challenges to be overcome in introducing universal VL. These include decontamination, tracking and cost: individual pressures will vary between different hospitals.
Before and during the feasibility study, the C-MAC © blades were decontaminated by anaesthetic assistants in theatre sluices with proprietary decontamination fluid. However, to be compliant with regulations and for staff safety, we introduced standardized decontamination and tracking under the control of the sterile services department. The increased turnaround time dramatically increased the number of blades required to service the theatre suites. In hospitals that do not have inhouse sterile services departments, the challenge may be even greater. Regarding cost, there is no doubt that VL can increase costs. However, there are a number of different solutions in terms of devices and commercial solutions. The 2015 Difficult Airway Society guidelines state that VL should be immediately available wherever intubation is performed and that anaesthetists should be trained and expert in the technique. 38 As such, VL is now a mainstream technique, and it is likely that most hospitals will need to increase provision. 7 In constructing a business case to support the planned change, we were careful to include not only direct costs but also other benefits. The first and most important benefit, we believe, is patient safety. However, decreased difficult, delayed, and failed intubations have clinical and financial impact, including: fewer delays in theatre; less use of expensive back-up intubation techniques; 27 fewer complications of delayed intubation; 23, 24, 39, 40 fewer resultant cancellations of operations, and fewer ICU admissions as a consequence of airway complications. 24 Finally, conversion to universal VL use has made us compliant with guidance from the MHRA 9 and the Association of Anaesthetists of Great Britain and Ireland 41 regarding decontamination and traceability of laryngoscopes in a manner that we previously were not.
Conclusions
We have used a formal trial of universal VL, over a prolonged period, to determine the suitability and feasibility of conversion from direct laryngoscopy to VL as first-choice technique. This method has enabled us to achieve unanimous departmental agreement on a change in practice, while also determining the minimal number of videolaryngoscope units necessary to achieve this safely. This structured assessment of feasibility demonstrates that a departmental conversion to universal VL is perceived by both anaesthetists and anaesthetic assistants to be beneficial to patient safety, team dynamics, human factors, quality of care, and quality of training. 
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